Search results
Merck KGaA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 11 hours agoMerck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 7 hours agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 15 hours agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday, Benzinga reports ...
Merck&Co earnings beat by $0.14, revenue topped estimates
Investing.com· 5 days agoMerck&Co earnings beat by $0.14, revenue topped estimates
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 9 hours agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 5 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 4 days agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
FOX 23 News Albany· 14 hours agoHuma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA,...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 4 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 6 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
